AIM ImmunoTech Inc. has entered into a Warrant Agency Agreement with Equiniti Trust Company, LLC as part of its Rights Offering. This agreement establishes the terms under which Equiniti will act as the warrant agent for the newly issued warrants. This move is expected to facilitate the management of warrants included in the units sold during the offering
Company Information
Company
AIM ImmunoTech
Location
Ocala, Florida, United States
About
AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s lead product is a first-in-class investigational drug called Ampligen® (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials for globally important cancers, viral diseases and disorders of the immune system.
OcalaBiotechnologyHealthcareHealth CareTherapeuticsPharmaceutical